The activities of the interferon-induced enzyme 2 -5' oligoadenylate synthetase in peripheral blood mononuclear cells were determined in patients with vkal hepatitis. Increased levels of the enzymewere found in patients with acute type B hepatitis at the early phase and also in those with chronic type B hepatitis at the active stage. The levels of this enzymeactivity were not significantly increased in patients with acute type A hepatitis or in those with acute type non A non B hepatitis. However, in two patients with acute type A hepatitis the levels of this enzymewere elevated shortly at the onset. These results support the hypothesis that an endogenous interferon response in patients with acute type A hepatitis and in those with acute type B hepatitis may be instrumental in the modulation of these types of hepatitis virus infections. Whereas hepatitis non A non B virus replication in patients with acute type non A non B hepatitis may be associated with poor interferon response. The activities of the enzymein peripheral blood mononuclear cells were determined in patients with chronic type B hepatitis during interferon therapy. Increased levels of the enzyme were found in all patients during interferon therapy. This increase correlated well with the decreased DNA-polymeraseactivities. The data also showed that assay of this enzymeactivity is useful to determine the optimal dosage and meansof interferon therapy for chronic type B hepatitis.
The activities of the interferon-induced enzyme 2 -5' oligoadenylate synthetase in peripheral blood mononuclear cells were determined in patients with vkal hepatitis. Increased levels of the enzymewere found in patients with acute type B hepatitis at the early phase and also in those with chronic type B hepatitis at the active stage. The levels of this enzymeactivity were not significantly increased in patients with acute type A hepatitis or in those with acute type non A non B hepatitis. However, in two patients with acute type A hepatitis the levels of this enzymewere elevated shortly at the onset. These results support the hypothesis that an endogenous interferon response in patients with acute type A hepatitis and in those with acute type B hepatitis may be instrumental in the modulation of these types of hepatitis virus infections. Whereas hepatitis non A non B virus replication in patients with acute type non A non B hepatitis may be associated with poor interferon response. The activities of the enzymein peripheral blood mononuclear cells were determined in patients with chronic type B hepatitis during interferon therapy. Increased levels of the enzyme were found in all patients during interferon therapy. This increase correlated well with the decreased DNA-polymeraseactivities. The data also showed that assay of this enzymeactivity is useful to determine the optimal dosage and meansof interferon therapy for chronic type B hepatitis. A sample of 5 to 10 mlvenousbloodwas taken from each subject and heparinized. PBMcells were isolated by Ficoll-Hypaque gradient centrifugation immediately. The cells were washed twice in 5 ml phosphate buffered saline (PBS) and counted in a hematocytometer. They were pelleted in a microtest tube and frozen at -80 G until the protein assay was started. After the cells were suspended at 5 x 106 cells in about 0.1 ml lysisbuffer; 20 mMHepes buffer, pH 7.5, 5 mMMgCl2, 120 mM KC1, 1 mMdithiothreitol, 10% (v/v) glycerol containing 0.5% (v/v) Nonidet P-40 (NP-40), lysis was carried out at 4°C and the extract was centrifuged at 10,000 rpm for 15 min. 
RESULTS
The results of study 1 are shown in Table 1 (Fig. 2) . Results of study 2 are given in Table 2 and Figure 3 . The latter shows the changesof 2-5AS in PBMcells and DNA-Pin sera of patients receiving HLBI therapy. The enzyme levels were increased remarkably at 12 hours after the first injection at the onset of therapy, and remained elevated during therapy. Induced 2-5AS levels were associated with the dosage of HLBI. This increase in enzyme levels correlated well with the decreased DNA-P activities. Two weeks later the DNA-Pactivities in 
